Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.

Former Pear CEO joins Swing board — did he invest?

My colleague Allison DeAngelis spotted a familiar character pop up in a fresh SEC filing from Swing Therapeutics, developer of a n FDA-cleared app for the treatment of fibromyalgia .

Swing Therapeutics has raised $11 million and former Pear Therapeutics CEO Corey McCann is now on the company’s board, according to the filing from last week .

To read the rest of this story subscribe to STAT+. Subscribe Log In

See Full Page